4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-355562
Director sold 10,000 shares at an average $111.43 ($1,114,261)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WILSON JAMES N · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-14 | Sale : show line 1 in the form 10b5-1 | −3,053 | $110.49 | $337,341 | 1,081,490 | I |
| 2026-08-14 | Sale : show line 2 in the form 10b5-1 | −4,668 | $111.44 | $520,214 | 1,076,822 | I |
| 2026-08-14 | Sale : show line 3 in the form 10b5-1 | −2,279 | $112.64 | $256,706 | 1,074,543 | I |
| Open-market sales · 10,000 sh · avg $111.43 · $1,114,261 | ||||||
Loading xslF345X06/ownership.xml…